Companies: 10,795·Total market cap: $144.5T

Dialogue Health Technologies Inc.

Dialogue Health Technologies Inc.

DLHTFOTCHealthcare

$3.79

+$0.02(+0.59%)

Market Cap$254797554

P/E Ratio—

52W High$3.7922

52W Low$2.07

Avg Volume8

Open$3.79

Beta2.66

Net Income Financials Revenue

Dialogue Health Technologies Inc. (DLHTF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

DLHTF · net income · updated Jun 9, 2026

Core profitability metrics

DLHTF · net income · margin · TTM · CAGR

Net income was −$26.0M for FY2022 (fiscal year ending 2022-12-31), up 89.7% year-over-year. Net profit margin was -29.8%.

FY2022 Net Income−$26.0M▲ +89.7% YoY

Trailing 12M (TTM)−$18.9Mtrailing 4 quarters sum

Net Profit Margin-29.8%−$26.0M ÷ $87.1M

YoY Change+89.7%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · DLHTF net income history · DLHTF profit margin

Annual net income data

DLHTF · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2022Loss−$26.0M▲ +89.7%-29.8%$87.1M

FY2021Loss−$251.4M▼ 1142.4%-369.4%$68.0M

FY2020Loss−$20.2M▼ 68.0%-56.5%$35.8M

FY2019Loss−$12.0M▼ 19.4%-119.4%$10.1M

FY2018Loss−$10.1M—-251.3%$4.0M

Net income vs peers (Healthcare)

DLHTF vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Dialogue Health Technologies Inc.YOU

DLHTF

−$26.0M+89.7%-29.8%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Dialogue Health Technologies Inc. (DLHTF) reported net income of −$26.0M for FY2022 (fiscal year ending 2022-12-31), up 89.7% year-over-year. The net profit margin was -29.8% — meaning the company kept $-0.30 of every dollar of revenue as profit.

Dialogue Health Technologies Inc. has not yet achieved annual profitability based on available data (5 fiscal years). The company has reported net losses across all available periods.

Dialogue Health Technologies Inc.'s net profit margin was -29.8% for FY2022, based on the latest annual results.

Investors sometimes search for "Dialogue Health Technologies Inc. net worth" — the company's market capitalization is a separate figure from DLHTF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

DLHTF net income · 4 questions

Dialogue Health Technologies Inc. is not currently profitable on an annual basis. The company reported a net loss of $26.0M for FY2022.

is DLHTF profitabledoes DLHTF make a profitDLHTF profitabilityDLHTF profitable company

▸ Source: FMP /income-statement · GAAP · Dialogue Health Technologies Inc. · Dialogue Health Technologies Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026